TBP Study With Capecitabine Plus Minus Trastuzumab

Summary

This study is done in patients having Breast Cancer with metastasis (patients with positive receptor HER2) whose disease progressed after receiving Trastuzumab. The primary objective of this study is to compare the time until disease progression between the Treatment Arm CAPECITABINE and the Treatment Arm CAPECITABINE + TRASTUZUMAB The study has also other secondary and tertiary objectives.

Timeline

Start

2003-09

Primary completion

2011-01

Completion

2011-01

Drugs

Indications